Balloon Aortic Valvuloplasty Market Size, Growth, Share by 2031
من المتوقع أن يصل حجم سوق رأب الصمام الأبهري بالبالون إلى 190.27 مليون دولار أمريكي بحلول عام 2031 من 125.08 مليون دولار أمريكي في عام 2023. ومن المتوقع أن يسجل السوق معدل نمو سنوي مركب قدره 5.4٪ خلال الفترة 2023-2031. من المرجح أن تظل استراتيجيات البحث والتطوير الناشئة التي تساعد على تحسين عملية زرع الصمام الأبهري عبر القسطرة (TAVI) بمثابة اتجاهات رئيسية في السوق.
تحليل سوق عملية رأب الصمام الأبهري بالبالونValvuloplasty Market Analysis
تشمل العوامل التي تدفع نمو سوق أجهزة رأب الصمامات البالونية شيخوخة السكان السريعة وزيادة معدل انتشار تضيق الصمام الأبهري. أصبح تضيق الأبهر من أمراض الصمامات الأكثر شيوعًا التي تتطلب العلاج الجراحي. يمكن أن يكون رأب الصمام الأبهري بالبالون (BAV) مفيدًا لمجموعة واسعة من المرضى الذين يعانون من تضيق الأبهر، فضلاً عن كونه علاجًا جسريًا لاستبدال الصمام، إلى جانب دوره في إجراءات TAVI. تعد زيادة توافر عمليات السداد الطبية لأجهزة رأب الصمامات البالونية، والاعتماد المتزايد للعمليات الجراحية ذات الحد الأدنى من التدخل، والبنية التحتية الأفضل للرعاية الصحية من العوامل الإضافية التي تساهم في نمو السوق. عادةً ما تتضمن أساليب التدخل الجراحي البسيط شقوقًا أصغر باستخدام أدوات وتقنيات متخصصة للوصول إلى القلب، مما قد يؤدي إلى إقامة أقصر في المستشفى وتندب أقل. بالإضافة إلى ذلك، تستثمر مؤسسات الرعاية الصحية في تدريب فرقها الطبية والحصول على المعدات اللازمة لتلبية الطلب المتزايد على جراحات BAV وTAVI ذات التدخل الجراحي البسيط، وبالتالي تزويد المرضى بخيارات علاجية محسنة وتجارب رعاية صحية شاملة أفضل. وهكذا، يشهد سوق رأب الصمام الأبهري بالبالون نموًا ملحوظًا.
نظرة عامة على سوق رأب الصمام الأبهري بالبالون
يموت أكثر من نصف المرضى الذين يعانون من مرض صمام القلب الحاد خلال عامين من ظهور الأعراض. تشير نتائج الاستطلاع التي نشرتها Global Heart Hub في Heart Valve Voice Canada 2020 إلى أن 3٪ فقط من الكنديين الذين تبلغ أعمارهم 60 عامًا فما فوق على علم بتضيق الأبهر. ولذلك فإن زيادة الوعي والكشف المبكر عن أمراض صمامات القلب أمر ضروري للمرضى، إلى جانب أولئك الذين يعتمدون عليهم والمجتمع المحلي. شكلت جمعية القلب والأوعية الدموية الكندية مجموعة عمل لاستراتيجية أمراض صمامات القلب لمعالجة الفجوات في رعاية أمراض صمامات القلب في كندا. في يناير 2021، تلقت شركة Medtronic إشارة موسعة من وزارة الصحة الكندية لنظام Evolut TAVI. تعد منصة TAVI الخاصة بشركة Medtronic النظام الوحيد المرخص لكل من الصمامات الأبهري ثنائية الشرف (المرضى ذوي الخطورة المتوسطة أو العالية). يشار إلى دواء Evolut في الدولة لعلاج مرضى تضيق الأبهر الشديد في جميع فئات المخاطر. في سبتمبر 2021، حصلت شركة أبوت على موافقة إدارة الغذاء والدواء الأمريكية (FDA) على عقار Portico المزود بنظام استبدال الصمام الأبهري عبر القسطرة (TAVR) FlexNav لعلاج الأشخاص الذين يعانون من تضيق الأبهر الشديد المصحوب بأعراض والمعرضين لخطر كبير لإجراء جراحة القلب المفتوح.
تخصيص البحث ليناسب متطلباتك
يمكننا تحسين وتخصيص التحليل والنطاق الذي لم يتم تلبيته من خلال عروضنا القياسية. ستساعدك هذه المرونة في الحصول على المعلومات الدقيقة اللازمة لتخطيط أعمالك واتخاذ القرارات.
سوق رأب الصمام الأبهري بالبالون:
معدل النمو السنوي المركب (2023 - 2031)5.4%- حجم السوق 2023
125.08 مليون دولار أمريكي - حجم السوق 2031
190.27 مليون دولار أمريكي
ديناميات السوق
- ارتفاع معدل انتشار تضيق الصمام الأبهري
- تزايد الطلب على الإجراءات طفيفة التوغل
- التقدم في تقنيات استبدال الصمام الأبهري
اللاعبين الرئيسيين
- ب براون إس إي
- شركة تي تي الطبية
- بالتون
- بيكتون ديكنسون وشركاه
- شركة إدواردز لعلوم الحياة
- بالت
- فينوس ميدتيك هانغتشو إنك.
- نوميد
- simeks
- أوسيبكا
نظرة عامة إقليمية
- أمريكا الشمالية
- أوروبا
- آسيا والمحيط الهادئ
- أمريكا الجنوبية والوسطى
- الشرق الأوسط وأفريقيا
تجزئة السوق
نوع المنتج- بالونات غير متوافقة
- بالونات شبه متوافقة
- يعرض نموذج PDF بنية المحتوى وطبيعة المعلومات من خلال التحليل النوعي والكمي.
محركات وفرص سوق جراحة الصمام الأبهري بالبالون
الطلب المتزايد على الإجراءات طفيفة التوغل يدعم نمو السوق
The soaring demand for minimally invasive techniques in valve replacement surgeries reflects a significant shift in medical practices and patient preferences. In a minimally invasive aortic valvuloplasty, the heart's aortic valve is repaired and, if needed, replaced through TAVI procedures. Minimally invasive techniques are driven by the desire to reduce the invasiveness of procedures, minimize the associated risks, and promote faster recovery times.
All branches of medicine, including cardiology, are witnessing an increase in the demand for less invasive procedures because of several benefits over traditional open-heart surgery. Compared to open-heart surgery, patients who undergo minimally invasive procedures usually have a shorter recovery time. In addition, minimally invasive techniques have a lower risk of complications and result in fewer scars compared to open cardiac surgery. Surgeons have adopted these techniques due to advancements in medical devices, and improved surgical skills can further facilitate widespread adoption. As BAV is a minimally invasive technique that can be used to treat a variety of heart problems, including aortic valve stenosis, the market for BAV devices is driven by the increased demand for minimally invasive procedures.
Advancements in Aortic Valve Replacement Technologies
Patients with heart conditions experience improved symptoms within a shorter period when treated with transcatheter procedures compared with surgical interventions. Minimally invasive surgical techniques, such as TAVI, have modernized the treatment of aortic stenosis due to advancements. Additionally, improvements in design have led to the development of stronger and biocompatible aortic valve replacements, which have enhanced patient outcomes and lowered the risk of complications. A few technological advancements by the companies in balloon aortic valvuloplasty and aortic valve replacement devices are mentioned below:
- In January 2023, Abbott received FDA approval for the Navitor TAVI system to treat patients with severe aortic stenosis and those who are ineligible for open-heart surgery. Navitor has been newly introduced in the company's extensive transcatheter structural heart portfolio; it offers physicians and patients less invasive treatment alternatives for a range of serious heart conditions.
- In September 2020, Boston Scientific introduced the ACURATE neo2 aortic valve system in Europe. The next-generation TAVI technology—a new platform designed with multiple features to improve the clinical performance of the original ACURATE neo platform—had an extended indication for patients with aortic stenosis compared to the aortic valve system of the previous generation.
Therefore, technological advancements are offering lucrative opportunities for the balloon aortic valvuloplasty market growth.
Balloon Aortic Valvuloplasty Market Report Segmentation Analysis
The key segment that contributed to the derivation of the balloon aortic valvuloplasty market analysis is product type.
Based on product type, the balloon aortic valvuloplasty market is bifurcated into non-compliant balloons and semi-compliant balloons. The non-compliant balloons segment held a larger market share in 2023 and is expected to register a higher CAGR in the market during 2023–2031.
Balloon Aortic Valvuloplasty Market Share Analysis by Geography
The geographic scope of the balloon aortic valvuloplasty market report is mainly divided into five regions: North America, Asia Pacific, Europe, Middle East & Africa, and South & Central America.
North America held a significant share of the market. The growth of the market in this region is attributed to the rising prevalence of heart valve diseases, increasing initiatives by various organizations to raise awareness about heart valve diseases among the population, and advancements made in treatment devices. According to the Organization for Economic Co-operation and Development, the burden of cardiovascular diseases is increasing rapidly in Mexico. The risk factors associated with heart diseases among the adult and geriatric population are being addressed in Mexico via awareness programs. In response to these awareness programs, transcatheter aortic valve replacement surgeries have gained traction and are commonly preferred as an alternative to open-heart valve surgery. Cardiologists in Mexico City perform TAVI using the best technology and techniques. CMQ Hospitals is a leader in the TAVI procedure in Puerto Vallarta and Riviera Nayarit. The hospitals have a multidisciplinary team of professionals in interventional cardiology, guaranteeing comprehensive and personalized care for each patient.
The most common cause of aortic stenosis in Canada is degenerative valve disease due to aging, followed by congenital bicuspid aortic valve disease and rheumatic heart disease. As per the “Heart Valve Disease in Canada,” published by the Institute of Health Economics in March 2022, aortic stenosis and mitral regurgitation are the two most common heart valve diseases. About 2.5% of the country’s population is reported to have heart valve disease, which increases significantly after the age of 65, reaching 13% in people aged 75 and above. It is estimated that 1.5 million people aged above 65 will suffer from heart valve disease by 2040 in Canada.
In Canada, a significant number of market players offer TAVI products. Edwards Lifesciences, Boston Scientific Corporation, Medtronic Inc., JenaValve Technology, and Transcatheter Technologies GmbH are a few manufacturers operating in the market. These manufacturers have received regulatory approvals from the Canadian government. Edwards SAPIEN and Medtronic CoreValve systems have been granted licenses in Canada.
Balloon Aortic Valvuloplasty Market Report Scope
| Report Attribute | Details |
|---|---|
| Market size in 2023 | US$�125.08 Million |
| Market Size by 2031 | US$�190.27 Million |
| معدل النمو السنوي المركب العالمي (2023 - 2031) | 5.4% |
| البيانات التاريخية | 2021-2022 |
| فترة التنبؤ | 2024-2031 |
| القطاعات المغطاة | حسب نوع المنتج
|
| المناطق والبلدان المشمولة | أمريكا الشمالية
|
| قادة السوق وملفات تعريف الشركة الرئيسية |
|
- يعرض نموذج PDF بنية المحتوى وطبيعة المعلومات من خلال التحليل النوعي والكمي.
أخبار سوق جراحة الصمام الأبهري بالبالون والتطورات الأخيرة
يتم تقييم سوق رأب الصمام الأبهري بالبالون من خلال جمع البيانات النوعية والكمية بعد الأبحاث الأولية والثانوية، والتي تتضمن منشورات الشركات المهمة وبيانات الارتباط وقواعد البيانات. بعض التطورات في سوق رأب الصمام الأبهري بالبالون مذكورة أدناه:
- أطلقت شركة أبوت أحدث جيل من نظام TAVI، Navitor، في الهند، مما يجعل الجهاز ذو التدخل الجراحي البسيط متاحًا للأشخاص الذين يعانون من تضيق الأبهر الشديد والذين يتعرضون لمخاطر جراحية عالية أو شديدة في البلاد. يتميز Navitor بسوار قماشي فريد (NaviSeal) يعمل مع دورة القلب لتقليل أو منع التدفق العكسي للدم عبر إطار الصمام، المعروف باسم التسرب المجاور للصمام. (المصدر: أبوت، بيان صحفي، ديسمبر 2022)
- أبرمت شركة Keystone Heart, Ltd. اتفاقية توزيع حصرية مع شركة InterValve Medical Inc. لبيع وتسويق مجموعتها من منتجات رأب الصمام الأبهري بالبالون في الولايات المتحدة. وبموجب الاتفاقية، بدأت شركة Keystone Heart Ltd. بيع القسطرة البالونية V8 وTAV8 لرأب الصمام الأبهري (InterValve Medical) في السوق الأمريكية. (المصدر: Keystone Heart, Ltd؛ بيان صحفي، مارس 2021)
تغطية تقرير سوق رأب الصمام الأبهري بالبالون والتسليمات
يقدم تقرير “حجم وتوقعات سوق رأب الصمام الأبهري بالبالون (2021-2031)” تحليلاً مفصلاً للسوق يغطي المجالات التالية:
- حجم سوق رأب الصمام الأبهري بالبالون والتوقعات على المستويات العالمية والإقليمية والقطرية لجميع قطاعات السوق الرئيسية المشمولة ضمن النطاق
- اتجاهات سوق رأب الصمام الأبهري بالبالون بالإضافة إلى ديناميكيات السوق مثل السائقين والقيود والفرص الرئيسية
- تحليل PEST وSWOT مفصل
- تحليل سوق رأب الصمام الأبهري بالبالون الذي يغطي اتجاهات السوق الرئيسية والإطار العالمي والإقليمي واللاعبين الرئيسيين واللوائح وتطورات السوق الأخيرة
- تحليل المشهد الصناعي والمنافسة الذي يغطي تركيز السوق وتحليل الخريطة الحرارية واللاعبين البارزين والتطورات الأخيرة لسوق رأب الصمام الأبهري بالبالون.
- ملفات تعريف الشركة التفصيلية
Report Coverage
Revenue forecast, Company Analysis, Industry landscape, Growth factors, and Trends
Segment Covered
This text is related
to segments covered.
Regional Scope
North America, Europe, Asia Pacific, Middle East & Africa, South & Central America
Country Scope
This text is related
to country scope.
Frequently Asked Questions
The estimated value of the balloon aortic valvuloplasty market can reach US$ 190.27 million by 2031.
North America region dominated the balloon aortic valvuloplasty market in 2023.
B Braun SE, TT Medical, Inc., Balton, Becton Dickinson and Co, Edwards Lifesciences Corp, Balt, Venus MedTech HangZhou Inc., NuMED, simeks, and OSYPKA are among the key market players in the balloon aortic valvuloplasty market.
The global balloon aortic valvuloplasty market is estimated to register a CAGR of 5.4% during the forecast period 2023–2031.
The rising prevalence of aortic valve stenosis and increasing demand for minimally invasive procedures are the most influential factors responsible for market growth.
The List of Companies - Balloon Aortic Valvuloplasty Market
- B Braun SE
- TT Medical, Inc.
- Balton
- Becton Dickinson and Co
- Edwards Lifesciences Corp
- Balt
- Venus MedTech HangZhou Inc
- NuMED
- simeks
- OSYPKA
The Insight Partners performs research in 4 major stages: Data Collection & Secondary Research, Primary Research, Data Analysis and Data Triangulation & Final Review.
- Data Collection and Secondary Research:
As a market research and consulting firm operating from a decade, we have published and advised several client across the globe. First step for any study will start with an assessment of currently available data and insights from existing reports. Further, historical and current market information is collected from Investor Presentations, Annual Reports, SEC Filings, etc., and other information related to company’s performance and market positioning are gathered from Paid Databases (Factiva, Hoovers, and Reuters) and various other publications available in public domain.
Several associations trade associates, technical forums, institutes, societies and organization are accessed to gain technical as well as market related insights through their publications such as research papers, blogs and press releases related to the studies are referred to get cues about the market. Further, white papers, journals, magazines, and other news articles published in last 3 years are scrutinized and analyzed to understand the current market trends.
- Primary Research:
The primarily interview analysis comprise of data obtained from industry participants interview and answers to survey questions gathered by in-house primary team.
For primary research, interviews are conducted with industry experts/CEOs/Marketing Managers/VPs/Subject Matter Experts from both demand and supply side to get a 360-degree view of the market. The primary team conducts several interviews based on the complexity of the markets to understand the various market trends and dynamics which makes research more credible and precise.
A typical research interview fulfils the following functions:
- Provides first-hand information on the market size, market trends, growth trends, competitive landscape, and outlook
- Validates and strengthens in-house secondary research findings
- Develops the analysis team’s expertise and market understanding
Primary research involves email interactions and telephone interviews for each market, category, segment, and sub-segment across geographies. The participants who typically take part in such a process include, but are not limited to:
- Industry participants: VPs, business development managers, market intelligence managers and national sales managers
- Outside experts: Valuation experts, research analysts and key opinion leaders specializing in the electronics and semiconductor industry.
Below is the breakup of our primary respondents by company, designation, and region:
Once we receive the confirmation from primary research sources or primary respondents, we finalize the base year market estimation and forecast the data as per the macroeconomic and microeconomic factors assessed during data collection.
- Data Analysis:
Once data is validated through both secondary as well as primary respondents, we finalize the market estimations by hypothesis formulation and factor analysis at regional and country level.
- Macro-Economic Factor Analysis:
We analyse macroeconomic indicators such the gross domestic product (GDP), increase in the demand for goods and services across industries, technological advancement, regional economic growth, governmental policies, the influence of COVID-19, PEST analysis, and other aspects. This analysis aids in setting benchmarks for various nations/regions and approximating market splits. Additionally, the general trend of the aforementioned components aid in determining the market's development possibilities.
- Country Level Data:
Various factors that are especially aligned to the country are taken into account to determine the market size for a certain area and country, including the presence of vendors, such as headquarters and offices, the country's GDP, demand patterns, and industry growth. To comprehend the market dynamics for the nation, a number of growth variables, inhibitors, application areas, and current market trends are researched. The aforementioned elements aid in determining the country's overall market's growth potential.
- Company Profile:
The “Table of Contents” is formulated by listing and analyzing more than 25 - 30 companies operating in the market ecosystem across geographies. However, we profile only 10 companies as a standard practice in our syndicate reports. These 10 companies comprise leading, emerging, and regional players. Nonetheless, our analysis is not restricted to the 10 listed companies, we also analyze other companies present in the market to develop a holistic view and understand the prevailing trends. The “Company Profiles” section in the report covers key facts, business description, products & services, financial information, SWOT analysis, and key developments. The financial information presented is extracted from the annual reports and official documents of the publicly listed companies. Upon collecting the information for the sections of respective companies, we verify them via various primary sources and then compile the data in respective company profiles. The company level information helps us in deriving the base number as well as in forecasting the market size.
- Developing Base Number:
Aggregation of sales statistics (2020-2022) and macro-economic factor, and other secondary and primary research insights are utilized to arrive at base number and related market shares for 2022. The data gaps are identified in this step and relevant market data is analyzed, collected from paid primary interviews or databases. On finalizing the base year market size, forecasts are developed on the basis of macro-economic, industry and market growth factors and company level analysis.
- Data Triangulation and Final Review:
The market findings and base year market size calculations are validated from supply as well as demand side. Demand side validations are based on macro-economic factor analysis and benchmarks for respective regions and countries. In case of supply side validations, revenues of major companies are estimated (in case not available) based on industry benchmark, approximate number of employees, product portfolio, and primary interviews revenues are gathered. Further revenue from target product/service segment is assessed to avoid overshooting of market statistics. In case of heavy deviations between supply and demand side values, all thes steps are repeated to achieve synchronization.
We follow an iterative model, wherein we share our research findings with Subject Matter Experts (SME’s) and Key Opinion Leaders (KOLs) until consensus view of the market is not formulated – this model negates any drastic deviation in the opinions of experts. Only validated and universally acceptable research findings are quoted in our reports.
We have important check points that we use to validate our research findings – which we call – data triangulation, where we validate the information, we generate from secondary sources with primary interviews and then we re-validate with our internal data bases and Subject matter experts. This comprehensive model enables us to deliver high quality, reliable data in shortest possible time.
Get Free Sample For